Douglas Pagán
Finanzdirektor/CFO bei Jnana Therapeutics, Inc.
Aktive Positionen von Douglas Pagán
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
Jnana Therapeutics, Inc.
 Jnana Therapeutics, Inc. BiotechnologyHealth Technology Jnana Therapeutics, Inc. provides drug development services. The firm focuses on immunometabolism changing the metabolic pathways in immune cells to affect function; lysosomal function and mucosal defense. The company was founded by Stuart L. Schreiber, Ramnik Xavier, Joanne Kotz and Joel C. Barrish and is headquartered in Boston, MA. | Geschäftsführer | 26.04.2022 | - |
| Finanzdirektor/CFO | 26.04.2022 | - |
Karriereverlauf von Douglas Pagán
Ehemalige bekannte Positionen von Douglas Pagán
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| ALAUNOS THERAPEUTICS, INC. | Direktor/Vorstandsmitglied | 18.09.2018 | 18.09.2020 |
| Independent Dir/Board Member | 18.09.2018 | 18.09.2020 | |
KSQ Therapeutics, Inc.
 KSQ Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology KSQ Therapeutics, Inc. develops and deploys precision functional genomics to discover therapies that transform patient lives. The company was founded by Tim Wang and is headquartered in Cambridge, MA. | Finanzdirektor/CFO | 01.04.2019 | 31.05.2020 |
| Unternehmenssekretär | 01.04.2019 | 31.05.2020 | |
| PARATEK PHARMACEUTICALS, INC. | Comptroller/Controller/Auditor | 18.12.2014 | 05.04.2019 |
| Finanzdirektor/CFO | 18.12.2014 | 05.04.2019 | |
| ACCELERON PHARMA INC. | Finanzdirektor/CFO | 01.04.2008 | 01.12.2014 |
| Corporate Officer/Principal | 04.10.2012 | 01.12.2014 | |
| DICERNA PHARMACEUTICALS, INC. | Finanzdirektor/CFO | 26.05.2020 | - |
JPMorgan Investment Bank
 JPMorgan Investment Bank Investment Banks/BrokersFinance JPMorgan Investment Bank operates as an investment banking firm. The company is headquartered in Houston, TX. | Corporate Officer/Principal | - | - |
| BIOGEN INC. | Finanzdirektor/CFO | - | 15.11.2011 |
| JOHNSON & JOHNSON | Corporate Officer/Principal | - | - |
| ░░░░░░░░░░░░░ ░░░░░░ ░░░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - | - |
Ausbildung von Douglas Pagán
| Princeton University | Undergraduate Degree |
| Columbia Business School | Masters Business Admin |
Statistik
International
| Vereinigte Staaten | 13 |
Operativ
| Director of Finance/CFO | 6 |
| Corporate Officer/Principal | 4 |
| Undergraduate Degree | 1 |
Sektoral
| Health Technology | 10 |
| Consumer Services | 3 |
| Finance | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 5 |
|---|---|
| BRISTOL-MYERS SQUIBB COMPANY | Health Technology |
| JOHNSON & JOHNSON | Health Technology |
| BIOGEN INC. | Health Technology |
| PARATEK PHARMACEUTICALS, INC. | Health Technology |
| ALAUNOS THERAPEUTICS, INC. | Health Technology |
| Private Unternehmen | 5 |
|---|---|
Acceleron Pharma, Inc.
 Acceleron Pharma, Inc. BiotechnologyHealth Technology Acceleron Pharma, Inc. is a biopharmaceutical company, which engages in the discovery, development and commercialization of therapeutics to treat serious and rare diseases. Its product candidates include Luspatercept, designed to patients with chronic anemia associated within a wide range of blood diseases; ACE-083, designed for the treatment of focal muscle disorders; and Sotatercept, designed to treat pulmonary arterial hypertension. The company was founded by John L. Knopf and Thomas P. Maniatis in June 2003 and is headquartered in Cambridge, MA. | Health Technology |
JPMorgan Investment Bank
JPMorgan Investment Bank Investment Banks/BrokersFinance JPMorgan Investment Bank operates as an investment banking firm. The company is headquartered in Houston, TX. | Finance |
KSQ Therapeutics, Inc.
KSQ Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology KSQ Therapeutics, Inc. develops and deploys precision functional genomics to discover therapies that transform patient lives. The company was founded by Tim Wang and is headquartered in Cambridge, MA. | Health Technology |
Dicerna Pharmaceuticals, Inc.
 Dicerna Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Dicerna Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in discovering, developing and commercializing medicines that are designed to leverage ribonucleic acid interference (RNAi) to selectively silence genes that cause or contribute to disease. The firm uses its proprietary GalXC RNAi technology platform to build a pipeline in these therapeutic areas. The company was founded by Douglas M. Fambrough III, Mark A. Behlke, Roberto Guerciolini, James Craig Jenson, and John J. Rossi in October 2006 and is headquartered in Lexington, MA. | Health Technology |
Jnana Therapeutics, Inc.
Jnana Therapeutics, Inc. BiotechnologyHealth Technology Jnana Therapeutics, Inc. provides drug development services. The firm focuses on immunometabolism changing the metabolic pathways in immune cells to affect function; lysosomal function and mucosal defense. The company was founded by Stuart L. Schreiber, Ramnik Xavier, Joanne Kotz and Joel C. Barrish and is headquartered in Boston, MA. | Health Technology |
- Börse
- Insiders
- Douglas Pagán
- Erfahrung
